1. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6:92.

https://doi.org/10.1038/s41572-020-00224-3

PMid:33243986 PMCid:PMC7944998

2. Eskiizmir G. Tumor microenvironment in head and neck squamous cell carcinomas. Turk Arch Otorhinolaryngol. 2014;53:120-7.

https://doi.org/10.5152/tao.2015.1065

PMid:29391993 PMCid:PMC5782915

3. de Morais EF, Santos HBP, Cavalcante IL, Rabenhorst SHB, Dos Santos JN, Galvão HC, et al. Twist and E-cadherin deregulation might predict poor prognosis in lower lip squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127:318-29.

https://doi.org/10.1016/j.oooo.2018.11.003

PMid:30598410 

4. Woolman M, Tata A, Dara D, Meens J, D'Arcangelo E, Perez CJ, et al. Rapid determination of tumour stroma ratio in squamous cell carcinomas with desorption electrospray ionization mass spectrometry (DESI-MS): A proof-of-concept demonstration. Analyst. 2017;142:3522.

https://doi.org/10.1039/C7AN90066J

PMid:28862278 

5. Peltanova B, Raudenska M, Masarik M. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Molecular Cancer. 2019;18:63.

https://doi.org/10.1186/s12943-019-0983-5

PMid:30927923 PMCid:PMC6441173

6. Zhang XL, Jiang C, Zhang ZX. The tumor-stroma ratio is an independent predictor for survival in nasopharyngeal cancer. Oncol Res Treat. 2014;37:480-84.

https://doi.org/10.1159/000365165

PMid:25231688 

7. Hirata E, Sahai E. Tumor Microenvironment and Differential Responses to Therapy. Cold Spring Harb Perspect Med. 2017;7:a026781.

https://doi.org/10.1101/cshperspect.a026781

PMid:28213438 PMCid:PMC5495051

8. Mascitti M, Zhurakivska K, Togni L, Caponio VCA, Almangush A, Balercia P, et al. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma. Histopathology. 2020;77:810-22.

https://doi.org/10.1111/his.14202

PMid:32633006 

9. Rani P, Gupta AJ, Mehrol C, Singh M, Khurana N, Passey JC. Clinicopathological correlation of tumor‑stroma ratio and inflammatory cell infiltrate with tumor grade and lymph node metastasis in squamous cell carcinoma of buccal mucosa and tongue in 41 cases with review of literature. J Can Res Ther. 2020;16:445-51.

https://doi.org/10.4103/0973-1482.193113

PMid:32719249 

10. Alves A, Diel L, Ramos G. Tumor microenvironment and oral squamous cell carcinoma: A crosstalk between the inflammatory state and tumor cell migration. Oral Oncology. 2021;112:105038.

https://doi.org/10.1016/j.oraloncology.2020.105038

PMid:33129055 

11. van Pelt GW, Krol JA, Lips IM, Peters FP, van Klaveren D, Boonstra JJ, et al. The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer. Clin Transl Radiat Oncol. 2019;20:39-44.

https://doi.org/10.1016/j.ctro.2019.11.003

PMid:31886418 PMCid:PMC6906651

12. Wu J, Liang C, Chen M, Su W. Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis. Oncotarget. 2016;7:68954-65.

https://doi.org/10.18632/oncotarget.12135

PMid:27661111 PMCid:PMC5356603

13. Karpathiou G, Vieville M, Gavid M, Camy F, Dumollard JM, Magné N, et al. Prognostic significance of tumor budding, tumor-stroma ratio, cell nests size, and stroma type in laryngeal and pharyngeal squamous cell carcinomas. Head & Neck. 2019;41:1-10.

https://doi.org/10.1002/hed.25629

PMid:30620425 

14. Moher D, Liberati A, Tetzlaf J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9.

https://doi.org/10.7326/0003-4819-151-4-200908180-00135

PMid:19622511 

15. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-5.

https://doi.org/10.1007/s10654-010-9491-z

PMid:20652370 

16. Wang K, Ma W, Wang J. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma. J Thorac Oncol. 2012;7:1457-61.

https://doi.org/10.1097/JTO.0b013e318260dfe8

PMid:22843085 

17. Ünlü M, Çetínayak HO, Önder D, Ecevıt C, Akman F, Ikız AÖ, et al. The prognostic value of tumor-stroma proportion in laryngeal squamous cell carcinoma. Turk Patoloji Derg. 2012;29:27-35.

https://doi.org/10.5146/tjpath.2013.01144

PMid:23354793 

18. Choi JW, Lee D, Hyun SH. Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma. Clin Radiol. 2017;72:482-9.

https://doi.org/10.1016/j.crad.2017.01.019

PMid:28285707 

19. Almangush A, Heikkinen I, Bakhti N, Mäkinen LK, Kauppila JH, Pukkila M, et al. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers. Histopathology. 2018;72:1128-35.

https://doi.org/10.1111/his.13481

PMid:29427291 

20. Niranjan KC, Sarathy NA. Prognostic impact of tumor-stroma ratio in oral squamous cell carcinoma - A pilot study. Ann Diagn Pathol. 2018;35:56-61.

https://doi.org/10.1016/j.anndiagpath.2018.05.005

PMid:29787931 

21. Dourado MR, Miwa KYM, Hamada GB, Paranaíba LMR, Sawazaki-Calone Í, Domingueti CB, et al. Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding. Histopathology. 2020;76:906-18.

https://doi.org/10.1111/his.14070

PMid:31984527 

22. Giraldo NA, Sanchez-Salas R, Peske JD, Vano Y, Becht E, Petitprez F, et al. The clinical role of the TME in solid cancer. Br J Cancer. 2019;120:45-53.

https://doi.org/10.1038/s41416-018-0327-z

PMid:30413828 PMCid:PMC6325164

23. Almangush A, Bello IO, Heikkinen I, Hagström J, Haglund C, Kowalski LP, et al. Stromal categorization in early oral tongue cancer. Virchows Archiv. 2021; 478:925-32.

https://doi.org/10.1007/s00428-020-02930-5

PMid:32955604 PMCid:PMC8099799

24. van Pelt GW, Kjær-Frifeldt S, van Krieken JHJM, Al Dieri R, Morreau H, Tollenaar RAEM, et al. Scoring the Tumor-Stroma Ratio in Colon Cancer: Procedure and Recommendations. Virchows Arch. 2018;473:405-12.

https://doi.org/10.1007/s00428-018-2408-z

PMid:30030621 PMCid:PMC6182321

25. Bello IO, Wennerstrand PM, Suleymanova I, Siponen M, Qannam A, Nieminen P, et al. Biopsy quality is essential for preoperative prognostication in oral tongue cancer. APMIS. 2021;129:118-27.

https://doi.org/10.1111/apm.13104

PMid:33320967 

26. Mesker WE, Junggeburt JM, Szuhai K, de Heer P, Morreau H, Tanke HJ, et al. The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol. 2007;5:387-98.

https://doi.org/10.1155/2007/175276

PMid:17726261 PMCid:PMC4617992

27. Gujam FJ, Edwards J, Mohammed ZM, Going JJ, McMillan DC. The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer. Br J Cancer. 2014;111:157‑65.

https://doi.org/10.1038/bjc.2014.279

PMid:24874480 PMCid:PMC4090742

28. Downey CL, Thygesen HH, Sharma N, Shaaban AM. Prognostic significance of tumour stroma ratio in inflammatory breast cancer. Springerplus. 2015;4:68.

https://doi.org/10.1186/s40064-015-0852-7

PMid:25713761 PMCid:PMC4334919

29. Panayiotou H, Orsi NM, Thygesen HH, Wright AI, Winder M, Hutson R, et al. The prognostic significance of tumour‑stroma ratio in endometrial carcinoma. BMC Cancer. 2015;15:955.

https://doi.org/10.1186/s12885-015-1981-7

PMid:26674153 PMCid:PMC4682261

30. Chen Y, Zhang L, Liu W, Liu X. Prognostic significance of the tumor‑stroma ratio in epithelial ovarian cancer. Biomed Res Int. 2015;2015:589301.

https://doi.org/10.1155/2015/589301

PMid:26609529 PMCid:PMC4644548

31. Liu J, Liu J, Li J, Chen Y, Guan X, Wu X, et al. Tumor‑stroma ratio is an independent predictor for survival in early cervical carcinoma. Gynecol Oncol. 2014;132:81‑6.

https://doi.org/10.1016/j.ygyno.2013.11.003

PMid:24219981 

32. Lv Z, Cai X, Weng X, Xiao H, Du C, Cheng J, et al. Tumor‑stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation. Surgery. 2015;158:142‑50.

https://doi.org/10.1016/j.surg.2015.02.013

PMid:25890776 

33. Brooks JM, Menezes AN, Ibrahim M, Archer L, Lal N, Bagnall CJ, et al. Development and validation of a combined hypoxia and immune prognostic classifier for head and neck cancer. Clin Cancer Res. 2019;25:5315-28.

https://doi.org/10.1158/1078-0432.CCR-18-3314

PMid:31182433